﻿<?xml version="1.0" encoding="utf-8"?>
<projects xmlns:pb="http://www.acdi-cida.gc.ca/opendata/pb/1-0-0">
  <header>
    <headerInformation>International Development Projects - 2026-05-14 1:15:38 AM - all published projects</headerInformation>
    <language>English</language>
    <filter></filter>
  </header>
  <project>
    <projectNumber>CA-3-P010206001</projectNumber>
    <dateModified>2026-05-13T06:32:47</dateModified>
    <title>COVAX vaccine delivery and dose sharing mechanism</title>
    <description>This project aims to strengthen COVID-19 response and recovery by reducing COVID-19 related mortality and morbidity, particularly amongst vulnerable and priority-use populations in the Gavi Advance Market Commitment (AMC) 92 eligible economies. Through the Gavi COVAX Facility, support for the delivering and distributing COVID-19 vaccines would increase. The project supports the COVID-19 Delivery Support (CDS) envelope, which aims to accelerate vaccination to high-risk populations, scale-up vaccine delivery for target populations, and integrate COVID-19 into routine immunization and primary health systems. This project also provides CA$10M to Gavi to design and operationalize the dose- sharing mechanism and support dose donations, analysis and tracking.</description>
    <status>Operational</status>
    <start>2021-03-30T00:00:00</start>
    <end>2026-10-31T00:00:00</end>
    <countries />
    <executingAgencyPartner>Gavi, The Vaccine Alliance </executingAgencyPartner>
    <DACSectors>
      <DACSectors>COVID-19 control 100.00%</DACSectors>
    </DACSectors>
    <maximumContribution>100324072.00</maximumContribution>
    <ContributingOrganization></ContributingOrganization>
    <expectedResults>The expected outcomes of this project include: (1) increase access to COVID-19 vaccines for AMC 92 eligible economies, enabling the vaccination of high-priority populations, including healthcare workers, the elderly and vulnerable groups; (2) increase AMC 92 capacity to implement COVID-19 vaccination programs, including strengthened health system capacity to support the transition of COVID-19 vaccination programs into routine immunization programs as possible; and (3) increase and improve access to donated COVID-19 vaccines.</expectedResults>
    <resultsAchieved>Results achieved as of June 2023 include: (1) COVAX delivered over 1.754 billion vaccines to the Advance Market Commitment (AMC) 92 low and lower-middle-income countries; and (2) estimates show up to 75% of deaths averted in AMC 92 low-income countries are attributable to COVAX supported doses.</resultsAchieved>
    <aidType>Contributions to specific-purpose programmes and funds managed by implementing partners</aidType>
    <collaborationType>Bilateral</collaborationType>
    <financeType>Aid grant excluding debt reorganisation</financeType>
    <flowType></flowType>
    <reportingOrganisation>Global Affairs Canada</reportingOrganisation>
    <programName>YFMInternaAssistPartnershp&amp;Programing Br</programName>
    <selectionMechanism>Department-Initiated</selectionMechanism>
    <policyMarkers>
      <policyMarker level="1">Gender equality</policyMarker>
      <policyMarker level="1">Environmental sustainability (cross-cutting)</policyMarker>
    </policyMarkers>
    <regions>
      <region>Asia, regional</region>
      <region>Oceania, regional</region>
      <region>America, regional</region>
      <region>Africa, regional</region>
      <region>Europe, regional</region>
    </regions>
    <alternameImPositions />
    <budgets>
      <budget budgetType="Revised" startDate="2020-04-01T00:00:00" endDate="2021-03-31T00:00:00" valueDate="2021-03-30T00:00:00">75000000.00</budget>
      <budget budgetType="Revised" startDate="2021-04-01T00:00:00" endDate="2022-03-31T00:00:00" valueDate="2021-03-30T00:00:00">25324072.00</budget>
    </budgets>
    <Locations />
    <otherIdentifiers>
      <otherIdentifier otherIdentifierType="CRS Activity identifier">2021200285</otherIdentifier>
    </otherIdentifiers>
    <participatingOrgs>
      <participatingOrg number="0001015986" city="Geveva                             " province="Geneva" countryCode="CH " channelCode="47122" iatiid="47122">Gavi, The Vaccine Alliance </participatingOrg>
    </participatingOrgs>
    <programDataStructure />
    <relatedActivities>
      <relatedActivity relatedActivityType="Sibling">CA-3-P010206002</relatedActivity>
      <relatedActivity relatedActivityType="Sibling">CA-3-P010206004</relatedActivity>
    </relatedActivities>
    <transactions>
      <transaction transactionDate="2021-03-30T00:00:00" valueDate="2021-03-30T00:00:00" transactionType="Commitment" flowType="ODA" tiedStatus="Untied">100324072.00</transaction>
      <transaction transactionDate="2021-03-31T00:00:00" valueDate="2021-03-31T00:00:00" transactionType="Disbursement" flowType="ODA" tiedStatus="">75000000.00</transaction>
      <transaction transactionDate="2022-03-22T00:00:00" valueDate="2022-03-22T00:00:00" transactionType="Disbursement" flowType="ODA" tiedStatus="">25324072.00</transaction>
    </transactions>
  </project>
</projects>